Hematology
Omid Hamid, M.D.
Chief, Translational Research and Immuno-Oncology, The Angeles Clinic / Cedars-Sinai
Los Angeles, CA
Dr. Omid Hamid is one of the preeminent immuno-oncologists and melanoma specialists in the world. As Chief of Translational Research and Immuno-Oncology at The Angeles Clinic and Research Institute, a Cedars-Sinai affiliate, his research focuses on paradigm-shifting developments including targeted therapies and immunotherapies. His current work emphasizes new immunotherapeutic options for patients upon progression on PD-1 blockade, including bi-specific antibodies, adoptive T cell therapy, and c
25+
Years in Practice
Credentials
Education & Training
- MD: University of Southern California Keck School of Medicine
- Residency: Los Angeles County Hospital/USC Medical Center (Internal Medicine)
- Fellowship: USC Norris Comprehensive Cancer Center (Hematology and Oncology)
Clinical Focus
Subspecialties
Hematology & Oncology
Conditions & Treatments
CAR-T Cell Therapy
Practice Details
Hospital Affiliations
- Cedars-sinai Medical Center
Experience
25+ years in practice